Mutual Of America Capital Management LLC Avidity Biosciences, Inc. Transaction History
Mutual Of America Capital Management LLC
- $9.32 Billion
- Q3 2024
A detailed history of Mutual Of America Capital Management LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Mutual Of America Capital Management LLC holds 164,997 shares of RNA stock, worth $7.77 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
164,997
Previous 184,249
10.45%
Holding current value
$7.77 Million
Previous $7.53 Million
0.69%
% of portfolio
0.08%
Previous 0.08%
Shares
6 transactions
Others Institutions Holding RNA
# of Institutions
226Shares Held
96.1MCall Options Held
171KPut Options Held
196K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$514 Million0.05% of portfolio
-
Rtw Investments, LP New York, NY8.81MShares$415 Million6.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$406 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.51MShares$307 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$280 Million0.0% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.46B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...